Tradestie Institutional Equity Comparison Engine

ARCT vs DMAC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DMAC Overall Edge

DMAC Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DiaMedica Therapeutics Inc. Common Stock (DMAC) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ARCT counters with relative strength in Valuation. Fundamentally, ARCT trades at 2.5x Forward P/E with -311.2% operating margin (+6.7% YoY revenue) versus DMAC at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ARCT sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against DMAC sits in SURGE (14th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARCT
ARCT 2.5x vs DMAC N/M Fwd P/E
Growth & Margin Winner DMAC
Op Margin -311.2% vs 0.0% ยท YoY +6.7% vs +0.0%
Momentum & Technical Winner DMAC
1Y +8.5% vs +54.8% ยท 52W Pos 24% vs 55%
Options & Structure Winner DMAC
BREAKDOWN (7th %ile IV) vs SURGE (14th %ile IV)
ARCT NASDAQ
Arcturus Therapeutics Holdings Inc. Common Stock
Pharmaceutical Preparations
$8.43
+0.84% 1D
Market Cap $241.0M
1M Return -18.47%
1Y Return +8.49%
Forward P/E 2.5x
Unified AI Score
57.7 / 100 HOLD
Tech 60.0 Fund 62.0 Flow 72.0 Mom 60.0
DMAC NASDAQ
DiaMedica Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$8.39
-4.55% 1D
Market Cap $503.1M
1M Return +10.83%
1Y Return +54.8%
Forward P/E N/M
Unified AI Score
46.3 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ARCT +8.49% DMAC +54.8% Spread: +46.31 pp (DMAC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ARCT Revenue DMAC Revenue ARCT Op. Margin DMAC Op. Margin Margin Edge
FY2018 $20M $0M -138.5% -1352.2% ARCT
FY2019 $20M N/A -122.7% N/A ARCT
FY2020 $10M N/A -749.8% N/A ARCT
FY2021 $10M N/A -1641.3% N/A ARCT
FY2022 $210M N/A 5.9% N/A ARCT
FY2023 $170M N/A -46.9% N/A ARCT
FY2024 $150M N/A -62.8% N/A ARCT
FY2025 $80M N/A -93.0% N/A ARCT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ARCT (5) vs DMAC (5)
Institutional Metric ARCT DMAC Criterion Row Winner
Market Capitalization Scale $241.0M $503.1M Larger Scale DMAC
Trailing P/E Ratio Valuation 2.5x N/M Lower Multiple ARCT
Forward P/E Ratio Valuation 2.5x N/M Lower Multiple ARCT
Revenue Growth (YoY) Growth +6.7% +0.0% Higher Growth ARCT
Operating Margin (TTM) Profitability -311.2% 0.0% Higher Margin DMAC
Net Profit Margin Profitability -285.9% 0.0% Higher Margin DMAC
Return on Equity (ROE) Capital Efficiency -44.4% -114.6% Higher ROE ARCT
52-Week Range Position Momentum 24% ($6โ€“$18) 55% ($5โ€“$11) Stronger Trend DMAC
Beta / 30D Volatility Risk Regime 2.01ฮฒ ยท 127% Vol 1.72ฮฒ ยท 97% Vol Lower Realized Risk DMAC
Unified Institutional Score Composite Signal 57.7 / 100 (HOLD) 46.3 / 100 (HOLD) Higher Composite ARCT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ARCT vs DMAC Buy Guide
ARCT BREAKDOWN
42d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live ARCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DMAC SURGE
8d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live DMAC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ARCT nor DMAC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.